TrialCancer research and treatment2019

A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide.

Gun Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.